158 related articles for article (PubMed ID: 26267685)
1. [Effect of alprostadil on serum level of miRNA-155
in uremic patients].
Zhang W; Shi L; Zhang H; Wang C; Gao S; Ma Y; Li W; Liu J; Wang J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):735-41. PubMed ID: 26267685
[TBL] [Abstract][Full Text] [Related]
2. Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.
Samouilidou E; Pantelias K; Petras D; Tsirpanlis G; Bakirtzi J; Chatzivasileiou G; Tzanatos H; Grapsa E
Ther Apher Dial; 2014 Jun; 18(3):279-83. PubMed ID: 24119290
[TBL] [Abstract][Full Text] [Related]
3. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
4. Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis.
Ren T; Xiong J; Liu G; Wang S; Tan Z; Fu B; Zhang R; Liao X; Wang Q; Guo Z
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31427482
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
6. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
7. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
8. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
[TBL] [Abstract][Full Text] [Related]
9. Effect of blood purification on serum miR-126 and VEGF levels in the process of atherosclerosis in uremic patients under maintenance hemodialysis.
Zhao D; Shao H
Kaohsiung J Med Sci; 2018 Aug; 34(8):447-455. PubMed ID: 30041762
[TBL] [Abstract][Full Text] [Related]
10. Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels.
Preston GA; Barrett CV; Alcorta DA; Hogan SL; Dinwiddie L; Jennette JC; Falk RJ
Nephron; 2002 Dec; 92(4):817-23. PubMed ID: 12399626
[TBL] [Abstract][Full Text] [Related]
11. Dialysis-related transcriptomic profiling: the pivotal role of heparanase.
Zaza G; Masola V; Granata S; Pontrelli P; Sallustio F; Gesualdo L; Gambaro G; Grandaliano G; Lupo A
Exp Biol Med (Maywood); 2014 Jan; 239(1):52-64. PubMed ID: 24189015
[TBL] [Abstract][Full Text] [Related]
12. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
13. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.
Stockler-Pinto MB; Soulage CO; Borges NA; Cardozo LFMF; Dolenga CJ; Nakao LS; Pecoits-Filho R; Fouque D; Mafra D
Int Urol Nephrol; 2018 Feb; 50(2):347-354. PubMed ID: 29151180
[TBL] [Abstract][Full Text] [Related]
14. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
[TBL] [Abstract][Full Text] [Related]
15. [Inflammatoin, oxidative stress and carbonyl stress in uremic patients].
Li Z; Su BH; Mi XH; Liu XR; Fan JM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):123-5. PubMed ID: 16468659
[TBL] [Abstract][Full Text] [Related]
16. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells.
Plum J; Fleisch MC; Razeghi P; Fusshöller A; Lordnejad MR; Grabensee B
Kidney Blood Press Res; 2002; 25(4):195-201. PubMed ID: 12424420
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis.
Wu HY; Peng YS; Chen HY; Tsai WC; Yang JY; Hsu SP; Pai MF; Lu HM; Chiang JF; Ko MJ; Wen SY; Chiu HC
Medicine (Baltimore); 2016 Mar; 95(9):e2935. PubMed ID: 26945400
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
19. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Filippi C; Mantuano E; Sidoti A; Grazi G; Antonelli A; Angelini D; Petrone I; Mura C; Tolaini P; Saloi F; Ghezzi PM; Barsotti G; Palla R
Nephrol Dial Transplant; 2006 Mar; 21(3):756-62. PubMed ID: 16303780
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: A cross-sectional study.
Zhao JH; Zhu QS; Li YW; Wang LL
PLoS One; 2021; 16(1):e0245370. PubMed ID: 33471852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
